WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Week 4, S Metabolized by enzymes CYP2C9, Prevacid Inhibits action by competition CYP2C19, St. John's Wort Induces CYP2C9, Patient also taking Medication 2 Xanax, St. John's Wort Inhibits by competition CYP1A2, Amiodarone (new medication ) Inhibits by competition CYP3A4, R Metabolized by enzymes CYP1A2, CYP3A4 When inhibited Decreased breakdown of Warfarin, Prilosec Inhibits action by competition CYP2C19, Warfarin Configuration 1 R, Pepcid Weak inhibitors CYP3A4, Possible medications for heartburn H2 blockers Pepcid, St. John's Wort Inhibits by competition CYP3A4, R Metabolized by enzymes CYP3A4, Bactrim (may remain in system for 3 days ) Inhibits action CYP2C9, Zantac Weak inhibitors CYP3A4, Increased breakdown of Warfarin Leads to Increased risk ofblood clots, Possible medications for heartburn H2 blockers Zantac, Warfarin Configuration 2 S, Possible medications for heartburn Proton pump inhibitors Prilosec